Skip to main content

Publications

featured publications

  • Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial Cancer.

    European urology focus

    Authors: Niklas Klümper, Markus Eckstein

  • Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

    European urology

    Authors: Niklas Klümper, Francisco E Vera-Badillo, Markus Eckstein, Boris Hadaschik, Viktor Grünwald

  • Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.

    BMC urology

    Authors: Philipp Krausewitz, Thomas Büttner, Marthe von Danwitz, Richard Weiten, Alexander Cox, Niklas Klümper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Manuel Ritter, Jörg Ellinger

  • Re: Assessment of PD-L1, TROP2, and NECTIN-4 Expression in Penile Squamous Cell Carcinoma.

    European urology

    Authors: Johannes Linxweiler, Niklas Klümper, Jan Mink, Markus Eckstein, Kerstin Junker

  • Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.

    Lung cancer (Amsterdam, Netherlands)

    Authors: Jonas Saal, Tobias Bald, Markus Eckstein, Damian J Ralser, Peter Brossart, Jörg Ellinger, Michael Hölzel, Niklas Klümper

  • Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

    Journal of cancer research and clinical oncology

    Authors: Johannes Stein, Eliana Krappe, Anika Kremer, Marcus V Cronauer, Markus Essler, Alexander Cox, Niklas Klümper, Philipp Krausewitz, Jörg Ellinger, Manuel Ritter, Glen Kristiansen, Michael Majores

  • Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.

    Cureus

    Authors: Johannes Stein, Niklas Klümper, Pirmin Zöhrer, Thomas Büttner, Philipp Krausewitz, Manuel Ritter, Glen Kristiansen, Marieta Toma, Jörg Ellinger, Alexander Cox

  • Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.

    Cancers

    Authors: Thomas Büttner, Dimo Dietrich, Romina Zarbl, Niklas Klümper, Jörg Ellinger, Philipp Krausewitz, Manuel Ritter

  • Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.

    American journal of translational research

    Authors: Thomas Büttner, Romina Zarbl, Philipp Krausewitz, Sebastian Strieth, Glen Kristiansen, Markus Eckstein, Damian J Ralser, Michael Hölzel, Manuel Ritter, Jörg Ellinger, Dimo Dietrich, Niklas Klümper

  • Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.

    Histopathology

    Authors: Veronika Bahlinger, Annalena Branz, Pamela L Strissel, Reiner Strick, Fabienne Lange, Carol I Geppert, Niklas Klümper, Michael Hölzel, Sven Wach, Helge Taubert, Danijel Sikic, Bernd Wullich, Miriam Angeloni, Fulvia Ferrazzi, Lauri Diehl, Maria Kovalenko, Emon Elboudwarej, Juliane M Jürgensmeier, Arndt Hartmann, Markus Eckstein